doi : 10.1016/S1936-8798(21)01096-7
Volume 14, Issue 13, 12 July 2021, Pages A11-A15
MohammedAl-HijjiMDabAbdallahEl SabbaghMDcStephanieEl HajjMDaMohamadAlKhouliMDaBassimEl SabawiMDaAllisonCabalkaMDaWilliam R.MirandaMDaDavid R.HolmesMDaCharanjit S.RihalMDa
doi : 10.1016/j.jcin.2021.02.044
Volume 14, Issue 13, 12 July 2021, Pages 1393-1406
Coronary artery fistulas (CAFs) are rare coronary anomalies that are usually diagnosed incidentally with cardiac imaging. Small CAFs are generally asymptomatic and can close over time, while some untreated medium or large CAFs can enlarge, leading to clinical sequelae such as cardiac chamber enlargement or myocardial ischemia. With the advancement of transcatheter equipment and techniques, CAFs have been increasingly closed using a percutaneous approach. However, the procedure is not free of limitations given the risk for myocardial infarction, device embolization, and fistula recanalization. In this review, the authors illustrate the contemporary procedural considerations, techniques, and outcomes of transcatheter CAF closure.
Stefan P.SchumacherMDaWijnand J.StuijfzandMDaRuben W.de WinterMDaPepijn A.van DiemenMDaMichiel J.BomMDaHenkEveraarsMDaRoel S.DriessenMDaLaraKampermanBScaMarlyKockxBScaBram S.H.HagenBScaPieter G.RaijmakersMD, PhDbPeter M.van de VenPhDcAlbert C.van RossumMD, PhDaMaksymilian P.OpolskiMD, PhDdAlexanderNapMD, PhDaPaulKnaapenMD, PhDa
doi : 10.1016/j.jcin.2021.04.044
Volume 14, Issue 13, 12 July 2021, Pages 1407-1418
The authors sought to evaluate the impact of ischemic burden reduction after chronic total occlusion (CTO) percutaneous coronary intervention (PCI) on long-term prognosis and cardiac symptom relief.
StéphaneRinfretMD, SMPratik B.SandesaraMD
doi : 10.1016/j.jcin.2021.05.028
Volume 14, Issue 13, 12 July 2021, Pages 1419-1422
TimKinnairdMDabSeanGallagherMDaAndrewSharpPhDaMajdProttyMDaTariqSalimMDaPeterLudmanMDcSamuelCoptPhDdNickCurzenPhDeMamas A.MamasDPhilbf
doi : 10.1016/j.jcin.2021.04.034
Volume 14, Issue 13, 12 July 2021, Pages 1423-1430
The aims of this study were to use a national percutaneous coronary intervention (PCI) registry to study temporal changes in procedure volumes of PCI using rotational atherectomy (ROTA-PCI), the patient and procedural factors associated with differing quartiles of operator ROTA-PCI volume, and the relationship between operator ROTA-PCI volumes and in-hospital patient outcomes.
Hitinder S.GurmMDDevrajSukulMD, MSc
doi : 10.1016/j.jcin.2021.05.012
Volume 14, Issue 13, 12 July 2021, Pages 1431-1433
Dominick J.AngiolilloMD, PhDaDavideCaoMDbUsmanBaberMD, MScSamanthaSartoriPhDbZhongjieZhangMPHbGeorgeDangasMD, PhDbShamirMehtaMD, MScdCarloBriguoriMD, PhDeDavid J.CohenMD, MScfTimothyCollierMScgDariuszDudekMD, PhDhJavierEscanedMD, PhDiC. MichaelGibsonMD, MSjRobertGilMD, PhDkKurtHuberMDlUpendraKaulMDmRanKornowskiMDnMitchell W.KrucoffMDoVijayKunadianMB, BS, MDpDavid J.MoliternoMDqE. MagnusOhmanMDoKeithOldroydMB, ChB, MDrGennaroSardellaMDsSamin K.SharmaMDbRichardShlofmitzMDtGioraWeiszMDuBernhardWitzenbichlerMDvStuartPocockPhDgRoxanaMehranMDb
doi : 10.1016/j.jcin.2021.04.043
Volume 14, Issue 13, 12 July 2021, Pages 1434-1446
The aim of this study was to assess the impact of age on the safety and efficacy of ticagrelor monotherapy after percutaneous coronary intervention (PCI).
GarimaSharmaMDaDavid I.FeldmanMD, MPHaJohn A.BittlMDb
doi : 10.1016/j.jcin.2021.05.013
Volume 14, Issue 13, 12 July 2021, Pages 1447-1449
LeiSongMDabBoXuMBBSbcYundaiChenMDdYujieZhouMDeShaobinJiaMDfZhixiongZhongMDgXiSuMDhYitongMaMDiQiZhangMDjJianLiuMDkYangWangMSclChangdongGuanMSccMingZhengMDmShubinQiaoMDabRunlinGaoMDabFUTURE-II Trial Investigators
doi : 10.1016/j.jcin.2021.04.048
Volume 14, Issue 13, 12 July 2021, Pages 1450-1462
The aim of the present study was to evaluate the safety and efficacy of thinner strut Firesorb (100/125 ?m) sirolimus-eluting bioresorbable scaffolds (BRS) versus cobalt-chromium everolimus-eluting stents (CoCr-EES) in patients with coronary artery disease.
Robert Janvan GeunsMD, PhD
doi : 10.1016/j.jcin.2021.05.036
Volume 14, Issue 13, 12 July 2021, Pages 1463-1465
JulienTernacleMD, PhDaPhilippePibarotDVM, PhDaHoward C.HerrmannMDbSusheelKodaliMDcJonathonLeipsicMDdPhilippBlankeMDdWaelJaberMDeMichael J.MackMDfMarie-AnnickClavelDVM, PhDaErwanSalaunMD, PhDaEzequielGuzzettiMDaMohamed-SalahAnnabiMD, MScaMathieuBernierMDaJonathanBeaudoinMD, PhDaOmar K.KhaliqueMDcNeil J.WeissmanMDgPamelaDouglasMDhJeroenBaxMDi…Rebecca T.HahnMDcj
doi : 10.1016/j.jcin.2021.03.069
Volume 14, Issue 13, 12 July 2021, Pages 1466-1477
This study aimed to compare incidence and impact of measured prosthesis-patient mismatch (PPMM) versus predicted PPM (PPMP) after surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).
TarunChakravartyMDMoodyMakarMDYousifAhmadPhD
doi : 10.1016/j.jcin.2021.05.011
Volume 14, Issue 13, 12 July 2021, Pages 1478-1480
no abstract
HirokiUeyamaMDabToshikiKunoMD, PhDaMatthewHarringtonMDaHisatoTakagiMD, PhDcParasuramKrishnamoorthyMDbSamin K.SharmaMDbAnnapoornaKiniMDbStamatiosLerakisMD, PhDb
doi : 10.1016/j.jcin.2021.04.038
Volume 14, Issue 13, 12 July 2021, Pages 1481-1492
The aim of this study was to assess the impact of aortic valve replacement (AVR) on survival in patients with each subclass of low-gradient (LG) aortic stenosis (AS) and to compare outcomes following surgical AVR (SAVR) and transcatheter AVR (TAVR).
RüdigerLangeMDabcKetiVitanovaMDab
doi : 10.1016/j.jcin.2021.05.015
Volume 14, Issue 13, 12 July 2021, Pages 1493-1494
ShuichiKegaiMDHiroshiAkanumaMDYuichiKatagiriMD
doi : 10.1016/j.jcin.2021.04.040
Volume 14, Issue 13, 12 July 2021, Pages 1495-1496
LucaApruzziMDaSavinoAltizioMDbDilettaLoschiMDaLucaBertoglioMDaAmericoPe?aMDaSilviaAjelloMDbAlbertoZangrilloMDbAnna MaraScandroglioMDb
doi : 10.1016/j.jcin.2021.03.025
Volume 14, Issue 13, 12 July 2021, Pages 1497-1499
FerdiKahramanMDTahirBezginMDAziz InanCelikMDMetinCagdasPhD
doi : 10.1016/j.jcin.2021.04.031
Volume 14, Issue 13, 12 July 2021, Pages e147-e148
Shih-TsungChengMDaChih-JenLiuMDaHsuan-LiHuangMDabYu-LinKoMDacd
doi : 10.1016/j.jcin.2021.04.005
Volume 14, Issue 13, 12 July 2021, Pages e149-e150
MarouaneBoukhrisMDaJessicaForcilloMD, MSc, MPbcJeannotPotvinMDacMaximeRobert-HalabiMDaJean-FrançoisGobeilMDacJean-BernardMassonMDac
doi : 10.1016/j.jcin.2021.03.031
Volume 14, Issue 13, 12 July 2021, Pages e151-e153
PawelGasiorMD, PhDaKrzysztofBryniarskiMD, PhDbAndrzejOchalaMD, PhDaWojciechWojakowskiMD, PhDa
doi : 10.1016/j.jcin.2021.02.041
Volume 14, Issue 13, 12 July 2021, Pages e155-e156
PaoloBorettoMDaAlessandroDepaoliMDbFedericoConrottoMDaPierluigiOmedèMDaOvidioDe FilippoMDaAlessandroSerafiniMDbGiulio AntoninoStrazzarinoMDbPaoloFonioProfbGaetano MariaDe FerrariProfaFabrizioD’AscenzoMD, PhDa
doi : 10.1016/j.jcin.2021.03.022
Volume 14, Issue 13, 12 July 2021, Pages e157-e159
Jung-JoonChaMD, PhDDo-SunLimMD, PhD
doi : 10.1016/j.jcin.2021.05.004
Volume 14, Issue 13, 12 July 2021, Pages 1500-1501
Naveen L.PereiraMDCharanjit S.RihalMDMichael E.FarkouhMD, MSc
doi : 10.1016/j.jcin.2021.05.014
Volume 14, Issue 13, 12 July 2021, Page 1501
GuillemMuntané-CarolMDJuan J.Portero-PortazMDMarcelAlméndarezMDIsaacPascualMDLuc?aJunqueraMDAlbertoAlperiMD, PhDFrançoisPhilipponMDSiamakMohammadiMDCésarMor?sMD, PhDJosepRodés-CabauMD, PhD
doi : 10.1016/j.jcin.2021.04.020
Volume 14, Issue 13, 12 July 2021, Pages 1502-1503
Lauge?stergaardMD, PhDNanaK?berMD, PhDChristianTuxenMD, PhDThomasSehestedtMD, PhDNisH?stMD, PhDLarsS?ndergaardMD, DMScJawad H.ButtMDEvaHavers-BorgersenMBJeppe KofoedPetersenMBAndreas DalsgaardJensenMBGunnarGislasonMD, PhDChristianTorp-PedersenMD, DMScLarsK?berMD, DMScEmil L.Fosb?lMD, PhD
doi : 10.1016/j.jcin.2021.04.053
Volume 14, Issue 13, 12 July 2021, Pages 1503-1505
AymanElbadawiMDIslam Y.ElgendyMDHeshamAfifyMD, MSMennaallahEidMDMohamedHamedMDHesham A.AbowaliMDNeal S.KleimanMDMichael J.ReardonMDSamir R.KapadiaMDSachin S.GoelMD
doi : 10.1016/j.jcin.2021.03.047
Volume 14, Issue 13, 12 July 2021, Pages 1505-1507
Do you want to add Medilib to your home screen?